RELX Plc

LSE:REL.L

Sector

🏭 Industrials

Industries

📈 Financial Reports

📊 Big Data

🔬 Clinical Trials

🤝 Professional Services

🔍 Research & Consulting

Location

United Kingdom

Market Cap

USD 96.04 B

Share Price

USD 52.39

Avg Daily Volume

4,160,183

Change (1 day)

-0.44%

Change (1 year)

14.73%

Change (YTD)

15.40%

RELX Plc Enterprise Value to EBITDA (EV/EBITDA) on June 20, 2025: 23.48

RELX Plc Enterprise Value to EBITDA (EV/EBITDA) is 23.48 on June 20, 2025, a 6.63% change year over year. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.

RELX Plc 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 24.84 on June 20, 2025, which is 5.80% above the current Enterprise Value to EBITDA (EV/EBITDA).
RELX Plc 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 17.89 on June 20, 2025, which is -23.80% below the current Enterprise Value to EBITDA (EV/EBITDA).
RELX Plc average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is 22.76.

Daily

From:

To:

Zoom:

Key data

Date	Enterprise Value to EBITDA (EV/EBITDA)	Free Cash Flow Yield	Dividend Yield	Market Capitalization

LSE: REL.L

RELX Plc

CEO	Mr. Erik Engstrom M.Sc Econ, M.Sc Eng., MBA
IPO Date	July 1, 1988
Location	United Kingdom
Headquarters	1-3 Strand
Employees	34,580
Sector	🏭 Industrials
Industries Financial Reports 📊 Big Data 🔬 Clinical Trials 🤝 Professional Services 🔍 Research & Consulting

Description

RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals to progress in science and advance healthcare. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as increases the productivity. The Exhibitions segment is involved in the events business that combines face-to-face with data and digital tools to help customers learn about markets, source products, and complete transactions. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.